RedHill Advances Opaganib for Ebola Outbreak Response
Raleigh, North Carolina, August 31, 2026 RedHill Biopharma Ltd. announced an update on the emergency development of opaganib as...
Public Health
Advertisement
Moderna Wins FDA Approval for 2026-27 COVID Vaccines
Cambridge, Massachusetts, August 27, 2026 Moderna, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved supplemental...
Shionogi Expands Fetroja Role in U.S. Drug-Resistance Preparedness
Osaka, Japan – August 28, 2026 Shionogi & Co., Ltd. announced that the Biomedical Advanced Research and Development Authority...
Abbott and NACHC Expand Nationwide Food for Health Initiative
Abbott Park, Illinois and Bethesda, Maryland, August 17, 2026 Abbott and the National Association of Community Health Centers (NACHC)...
Bavarian Nordic Secures EU Approval for IMVANEX in Children
COPENHAGEN, Denmark, August 7, 2026 Bavarian Nordic announced that the European Commission (EC) has approved a Type II variation...
Advertisements
Pfizer’s PREVNAR 20 Selected for Québec Pediatric Program
KIRKLAND, Québec, Canada, July 29, 2026 Pfizer Canada ULC announced that PREVNAR 20™, its 20-valent pneumococcal conjugate vaccine, has...
Pfizer and BioNTech Win EU Approval for XFG COVID-19 Vaccine
NEW YORK and MAINZ, Germany, July 29, 2026 Pfizer Inc. and BioNTech SE announced that the European Commission (EC)...
FDA Moves to Revoke Two Petroleum-Based Food Color Additives
WASHINGTON, D.C., July 22, 2026 The U.S. Food and Drug Administration (FDA) has announced two significant regulatory actions aimed...
GHIT Fund Accelerates Portable Ebola Diagnostic Innovation
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
Atossa Unveils (Z)-Endoxifen Data for Rare Endocrine Disease
SEATTLE, July 21, 2026 Atossa Therapeutics has presented new preclinical mechanism-driven data supporting the therapeutic potential of (Z)-Endoxifen for...
Advertisement
